About
Videos and Webinars

Upcoming Webinars

Check back soon for more on our 2021 Webinar Series, or sign up for our email list and we will update you as they are announced.

15 Sept 2021 (details coming soon)

02 Dec 2021 (details coming soon)


Webinars On-Demand

Circulating Tumor Cell Analysis: Delivering on the Promise of Liquid Biopsy

CTC analysis via liquid biopsy (blood) allows for a less-invasive method to identify cancer cells and can prove helpful in prognosis, treatment selection, patient stratification, and patient monitoring. Our two distinguished speakers, with over 50 years of combined experience in the field, will walk through these applications and supporting data.


WATCH THE WEBINAR

Analytical Validation of CTC Enumeration using the RareCyte Platform and Implementation in a Global Clinical Trial

This webinar describes how the RareCyte platform for CTC analysis was validated in the Clinical Diagnostics Lab (CAP accredited CLIA Lab) at Eli Lilly. The results met the requirements of the Clinical Drug Study Team and the RareCyte platform was added to a global clinical trial for further evaluation in collaboration with a CRO. A short presentation on RareCyte CTC assays for enumeration, multi-biomarker analysis, and custom assay development capabilities follows.


WATCH THE WEBINAR

Videos

RarePlex® Panel and Developer Assays for CTC enumeration and characterization
Presented by Arturo Ramirez, Ph.D., Director of Oncology R&D
This 7 minute overview of RarePlex Panel Kits and Developer technology highlights available circulating tumor cell assays from RareCyte and presents an introduction to our assay design and validation.

Working with the RarePlex® Developer Kit
Presented by Edward Lo, Ph.D., Scientist, Assay Development Lead
Developer technology from RareCyte enables you to add up to two custom biomarkers to your CTC assay. This 5 minute video will walk you through each step of the Developer process and provide examples of completed assays.

RareCyte technology presentation at Harvard Medical School
RareCyte technology presentation at Harvard Medical School titled “High Performance Multiplexed Imaging and Microregion Retrieval for Sequencing” presented by Leighton Howells, Vice President of Business Development, and Kyla Teplitz, Sr. Product Manager.
RarePlex® Assays: Design and Analytical Validation
Presented by Dr. Tad George, Sr. VP of Biology R&D
RarePlex Assays are sensitive, specific, and reproducible assays for CTC detection and biomarker expression. Gain insight into the principles RareCyte applies to its assay design and validation process in this 11 minute video.

Tissue transcriptomics with CyteFinder® II Instruments
Presented by Jennifer Chow, PhD, Principal Scientist
This 5 minute overview of RareCyte’s spatial transcriptomics technology highlights how multiplex imaging and needle-based retrieval with the CyteFinder II platform enables discovery applications with FFPE and fresh frozen tissue samples.